AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand
· Delayed Price · Currency is NZD 3.750
0.00 (0.00%)
At close: Dec 5, 2025
AFT Pharmaceuticals Balance Sheet
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 12.1 | 11.11 | 12.04 | 4.75 | 7.94 | 3.21 | Upgrade
|
| Cash & Short-Term Investments | 12.1 | 11.11 | 12.04 | 4.75 | 7.94 | 3.21 | Upgrade
|
| Cash Growth | 13.22% | -7.72% | 153.53% | -40.19% | 147.43% | -47.56% | Upgrade
|
| Accounts Receivable | 36.95 | 43.2 | 41.01 | 39.62 | 29.87 | 29.23 | Upgrade
|
| Receivables | 36.95 | 43.2 | 41.01 | 39.62 | 29.87 | 29.23 | Upgrade
|
| Inventory | 57.84 | 48.48 | 49.06 | 42.4 | 33.5 | 33.65 | Upgrade
|
| Prepaid Expenses | - | 5.37 | 3.22 | 7.1 | 6.14 | 1.81 | Upgrade
|
| Other Current Assets | 0.09 | 0.19 | 0.41 | 0.74 | 0.1 | - | Upgrade
|
| Total Current Assets | 106.98 | 108.34 | 105.73 | 94.6 | 77.54 | 67.9 | Upgrade
|
| Property, Plant & Equipment | 3.6 | 3.25 | 3.82 | 3.37 | 3.36 | 3.79 | Upgrade
|
| Other Intangible Assets | 60.37 | 13.74 | 14.45 | 16.17 | 15.99 | 15.59 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.67 | - | 2.25 | 4.47 | 8.33 | 0.72 | Upgrade
|
| Long-Term Deferred Charges | - | 44.49 | 39.01 | 29.46 | 22.11 | 17.13 | Upgrade
|
| Total Assets | 171.62 | 169.82 | 165.26 | 148.06 | 127.32 | 105.13 | Upgrade
|
| Accounts Payable | 27.68 | 25.12 | 25.33 | 22.19 | 12.07 | 14.7 | Upgrade
|
| Accrued Expenses | 6.09 | 9.8 | 11.85 | 9.57 | 8.11 | 7.62 | Upgrade
|
| Short-Term Debt | 2.05 | 1.08 | - | 1.46 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 32.1 | - | - | 1 | 4 | 5.16 | Upgrade
|
| Current Portion of Leases | 0.85 | 0.73 | 0.8 | 0.57 | 0.54 | 0.61 | Upgrade
|
| Current Income Taxes Payable | 2 | 2.68 | 3.8 | 0.83 | 0.84 | - | Upgrade
|
| Other Current Liabilities | - | 3.86 | 4.29 | 4.16 | 3.48 | 4.01 | Upgrade
|
| Total Current Liabilities | 70.76 | 43.26 | 46.07 | 39.78 | 29.05 | 32.1 | Upgrade
|
| Long-Term Debt | - | 25.6 | 28.2 | 32.2 | 33.2 | 33.2 | Upgrade
|
| Long-Term Leases | 2.87 | 2.59 | 3.19 | 2.82 | 2.77 | 3.24 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 1.3 | - | - | - | - | Upgrade
|
| Total Liabilities | 73.64 | 72.74 | 77.46 | 74.8 | 65.02 | 68.54 | Upgrade
|
| Common Stock | 78.24 | 78.24 | 78.24 | 78.24 | 80.77 | 80.36 | Upgrade
|
| Retained Earnings | 20.95 | 19.54 | 9.26 | -5.2 | -15.85 | -41.26 | Upgrade
|
| Comprehensive Income & Other | -0.07 | -0.14 | 0.3 | 0.23 | -2.61 | -2.51 | Upgrade
|
| Total Common Equity | 99.12 | 97.64 | 87.8 | 73.27 | 62.31 | 36.59 | Upgrade
|
| Minority Interest | -1.14 | -0.56 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 97.99 | 97.08 | 87.8 | 73.27 | 62.31 | 36.59 | Upgrade
|
| Total Liabilities & Equity | 171.62 | 169.82 | 165.26 | 148.06 | 127.32 | 105.13 | Upgrade
|
| Total Debt | 37.87 | 30 | 32.19 | 38.05 | 40.51 | 42.22 | Upgrade
|
| Net Cash (Debt) | -25.77 | -18.89 | -20.15 | -33.3 | -32.57 | -39.01 | Upgrade
|
| Net Cash Per Share | -0.25 | -0.18 | -0.19 | -0.32 | -0.31 | -0.38 | Upgrade
|
| Filing Date Shares Outstanding | 104.87 | 104.87 | 104.87 | 104.87 | 104.71 | 104.64 | Upgrade
|
| Total Common Shares Outstanding | 104.87 | 104.87 | 104.87 | 104.87 | 104.7 | 104.58 | Upgrade
|
| Working Capital | 36.22 | 65.09 | 59.66 | 54.83 | 48.49 | 35.8 | Upgrade
|
| Book Value Per Share | 0.95 | 0.93 | 0.84 | 0.70 | 0.60 | 0.35 | Upgrade
|
| Tangible Book Value | 38.75 | 83.9 | 73.34 | 57.1 | 46.32 | 21 | Upgrade
|
| Tangible Book Value Per Share | 0.37 | 0.80 | 0.70 | 0.54 | 0.44 | 0.20 | Upgrade
|
| Machinery | - | 2.43 | 2.15 | 2.02 | 2.05 | 1.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.